ResidualPlaybeta Open the radar

Blood Running

Dead Unicorn · 2025 · $16.99 · Action · deal grade B

Measured on 2026-09-23 20:10 UTC, 12 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

  • Estimated net residual revenue: $330 to $495 per month
  • Opportunity: $557 per month at x1.35 dormancy
  • Estimated lifetime owners: 8.0k
  • 70% positive across 206 reviews · 2.9 reviews/month

Why it's flagged

  • Developer silent for 19 months
  • Studio quiet across its whole catalog
  • Last discounted 0 months ago, 10 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-09-09; the live figures above take precedence over any numbers in it.

Blood Running is a 2025 action title from Dead Unicorn offering solid gunplay mechanics but suffering from minimal post-launch support and a shrinking player base.

Blood Running sits in an awkward middle ground: it earned modest lifetime revenue and maintains a 70% positive ratio, yet active development appears dormant (no discount campaigns in 12 months, developer posts silent for 18+ months) and concurrent players have flatlined to single digits. The game is too young and too quiet to justify acquisition as a standalone asset, but the core gunplay feedback suggests a foundation worth evaluating if Dead Unicorn's catalog or IP becomes available at portfolio scale. Most realistic play is monitoring whether the studio pivots or winds down, then reassessing. Most realistic play: watch.

  • Risk: Developer studio appears to be in early-stage decline: only two titles on record, no public updates in 18 months, and zero promotional activity this year despite a mid-tier price point.
  • Risk: Concurrent player count has collapsed from peak to 1-2 active users; retention stands at 33%, suggesting the core loop did not sustain engagement beyond the first 30 hours.
  • Risk: 2% localization gap in German and modest international review spread (Japanese reviews present but sparse) indicate potential friction in non-English markets that went unaddressed.

This case as Markdown · Estimates carry ±30-50% error per title.